Structure |
Chemical Name |
CAS |
MF |
![Fluvastatin 3-Hydroxy-4,6-diene](/CAS/20200611/GIF/1207963-21-0.gif) |
Fluvastatin 3-Hydroxy-4,6-diene |
1207963-21-0 |
C24H24FNO3 |
![Cyclosporine iMpurity](/) |
Cyclosporine iMpurity |
|
|
![ThiaMine IMpurity](/CAS/20150408/GIF/CB42710453.gif) |
ThiaMine IMpurity |
|
C12H17ClN4OS |
![CitalopraM IMpurity](/) |
CitalopraM IMpurity |
|
|
![3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide](/CAS/20200119/GIF/CB42715458.gif) |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
![Tigecycline](/) |
Tigecycline |
|
|
![1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione](/CAS/20150408/GIF/1496551-72-4.gif) |
1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
1496551-72-4 |
C10H13ClN2O5 |
![1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-](/CAS/20180808/GIF/1020414-33-8.gif) |
1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
1020414-33-8 |
C22H25ClF3N |
![4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine](/CAS/20150408/GIF/CB42716066.gif) |
4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
1823431-32-8 |
C7H9Cl2N3OS |
![Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester](/CAS/20150408/GIF/866551-95-3.gif) |
Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester |
866551-95-3 |
C20H27NO7 |
![4',6'-Dinitro-2'-phenoxymethanesulfonanilide](/CAS/20150408/GIF/51765-56-1.gif) |
4',6'-Dinitro-2'-phenoxymethanesulfonanilide |
51765-56-1 |
C13H11N3O7S |
![5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride](/CAS/20150408/GIF/33778-93-7.gif) |
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride |
33778-93-7 |
C20H26ClNO4 |
![Blonanserin Impurity I](/) |
Blonanserin Impurity I |
|
|
![25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol](/CAS/20150408/GIF/1246302-95-3.gif) |
25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol |
1246302-95-3 |
C27H40D6O2 |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-95-7.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-95-7 |
C18H25N3O2 |
![3-(3-メチルベンゾイル)-1,1,1-トリフルオロアセトン](/CAS/GIF/53764-99-1.gif) |
3-(3-メチルベンゾイル)-1,1,1-トリフルオロアセトン |
53764-99-1 |
C11H9F3O2 |
![7-[(7S)-7-アミノ-5-アザスピロ[2.4]ヘプタン-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸](/CAS/GIF/127254-11-9.gif) |
7-[(7S)-7-アミノ-5-アザスピロ[2.4]ヘプタン-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸 |
127254-11-9 |
C19H18ClF2N3O3 |
![(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/254452-86-3.gif) |
(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
254452-86-3 |
C25H24FNO4 |
![Tafluprost Impurity 17](/) |
Tafluprost Impurity 17 |
|
|
![(E)-4-Acetoxy Tamoxifen](/CAS/GIF/76117-70-9.gif) |
(E)-4-Acetoxy Tamoxifen |
76117-70-9 |
C28H31NO3 |
![O-Acetyl Losartan](/CAS2/GIF/1006062-27-6.gif) |
O-Acetyl Losartan |
1006062-27-6 |
C24H25ClN6O2 |
![(2-クロロ-5-ヨードフェニル)(4-エトキシフェニル)メタノン](/CAS2/GIF/1103738-26-6.gif) |
(2-クロロ-5-ヨードフェニル)(4-エトキシフェニル)メタノン |
1103738-26-6 |
C15H12ClIO2 |
![6-(2,4-ジクロロフェニル)-1,2,4-トリアジン-3,5-ジアミン](/CAS/GIF/38943-76-9.gif) |
6-(2,4-ジクロロフェニル)-1,2,4-トリアジン-3,5-ジアミン |
38943-76-9 |
C9H7Cl2N5 |
![D-2'-DEOXYRIBOFURANOSYL-3-GUANYLUREA (Α/Β-MIXTURE)](/CAS/GIF/570410-72-9.gif) |
D-2'-DEOXYRIBOFURANOSYL-3-GUANYLUREA (Α/Β-MIXTURE) |
570410-72-9 |
C7H14N4O4 |
![rac 5-Keto Fluvastatin](/CAS/20180906/GIF/1160169-39-0.gif) |
rac 5-Keto Fluvastatin |
1160169-39-0 |
C24H24FNO4 |
![9-Piperazino Ofloxacin](/CAS/GIF/197291-75-1.gif) |
9-Piperazino Ofloxacin |
197291-75-1 |
C18H20FN3O4 |
![Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED](/CAS/GIF/911661-90-0.gif) |
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED |
911661-90-0 |
C21H13I6NO5 |
![ペリンドプリルジケトピペラジン](/CAS/GIF/129970-98-5.gif) |
ペリンドプリルジケトピペラジン |
129970-98-5 |
C19H30N2O4 |
![Exemestane Impurity A](/) |
Exemestane Impurity A |
|
|
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/629652-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
629652-44-4 |
C22H19ClN2O5 |
![3-DesMorpholinyl-3-hydroxyethylaMino Gefitinib](/CAS/GIF/847949-56-8.gif) |
3-DesMorpholinyl-3-hydroxyethylaMino Gefitinib |
847949-56-8 |
C20H22ClFN4O3 |
![2,4-ビス(2-フラニルメチルアミノ)-5-スルファモイル安息香酸](/CAS/GIF/5046-19-5.gif) |
2,4-ビス(2-フラニルメチルアミノ)-5-スルファモイル安息香酸 |
5046-19-5 |
C17H17N3O6S |
![Cephalexin Sulfoxide](/CAS/GIF/56193-21-6.gif) |
Cephalexin Sulfoxide |
56193-21-6 |
C16H17N3O5S |
![N-Butyl Nor ScopolaMine Hydrochloride](/CAS/20180808/GIF/22235-98-9.gif) |
N-Butyl Nor ScopolaMine Hydrochloride |
22235-98-9 |
C20H28ClNO4 |
![(17R)-3-オキソ-11β,17-ジヒドロキシ-19-ノルプレグナ-4,9-ジエン-21-ニトリル](/CAS/GIF/86153-39-1.gif) |
(17R)-3-オキソ-11β,17-ジヒドロキシ-19-ノルプレグナ-4,9-ジエン-21-ニトリル |
86153-39-1 |
C20H25NO3 |
![2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-44-6.gif) |
2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity |
116182-44-6 |
C26H43NaO9 |
![3-Hydroxy CitalopraM](/CAS/GIF/411221-53-9.gif) |
3-Hydroxy CitalopraM |
411221-53-9 |
C20H21FN2O2 |
![5-(オキシラニルメトキシ)-2,3,4,9-テトラヒドロカルバゾール](/CAS/GIF/58457-32-2.gif) |
5-(オキシラニルメトキシ)-2,3,4,9-テトラヒドロカルバゾール |
58457-32-2 |
C15H17NO2 |
![6α-Methyl Hydrocortisone 21-HeMisuccinate](/CAS/GIF/119657-85-1.gif) |
6α-Methyl Hydrocortisone 21-HeMisuccinate |
119657-85-1 |
C26H36O8 |
![Hydroxy TorseMide](/CAS/GIF/99300-68-2.gif) |
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
![Hydroxy Varenicline N-Trifluoroacetate](/CAS/GIF/357426-10-9.gif) |
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
![N-ForMyl Valacyclovir](/CAS/GIF/847670-62-6.gif) |
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
![2-フルオロビフェニル-4-カルボン酸](/CAS/GIF/137045-30-8.gif) |
2-フルオロビフェニル-4-カルボン酸 |
137045-30-8 |
C13H9FO2 |
![テオフィルリジン塩酸塩](/CAS/GIF/116131-08-9.gif) |
テオフィルリジン塩酸塩 |
116131-08-9 |
C6H10ClN4O |
![1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole](/CAS/GIF/887583-89-3.gif) |
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
![Tetracyclics compound impurities](/) |
Tetracyclics compound impurities |
|
|
![Urapidil Impurity](/CAS/20211123/GIF/770-42-3.gif) |
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
![N'-(1-Methylazepan-4-yl)benzohydrazine](/CAS/GIF/117078-69-0.gif) |
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
![7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプト-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-1,4-ジヒドロ-4-オキソ-3-キノリンカルボン酸](/CAS/GIF/127199-06-8.gif) |
7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプト-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-1,4-ジヒドロ-4-オキソ-3-キノリンカルボン酸 |
127199-06-8 |
C19H18ClF2N3O3 |
![rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine](/CAS/GIF/58827-68-2.gif) |
rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine |
58827-68-2 |
C9H13N3O3S |
![rac a-Hydroxy Ibuprofen](/CAS/GIF/60057-62-7.gif) |
rac a-Hydroxy Ibuprofen |
60057-62-7 |
C13H18O3 |
![3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one](/CAS/GIF/171967-74-1.gif) |
3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one |
171967-74-1 |
C17H19N3O4 |
![5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one](/CAS/GIF/139756-31-3.gif) |
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
139756-31-3 |
C16H17ClN4O4S |
![5,7-ジフルオロクロマン-4-オン](/CAS2/GIF/844648-22-2.gif) |
5,7-ジフルオロクロマン-4-オン |
844648-22-2 |
C9H6F2O2 |
![3-アセチルオキシ-2-ブテン酸エチル](/CAS/GIF/29214-62-8.gif) |
3-アセチルオキシ-2-ブテン酸エチル |
29214-62-8 |
C8H12O4 |
![2-(ブロモメチル)-2-(2,4-ジクロロフェニル)-1,3-ジオキソラン-4-メタノール](/CAS/GIF/68751-57-5.gif) |
2-(ブロモメチル)-2-(2,4-ジクロロフェニル)-1,3-ジオキソラン-4-メタノール |
68751-57-5 |
C11H11BrCl2O3 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2511244-96-3.gif) |
INDEX NAME NOT YET ASSIGNED |
2511244-96-3 |
C27H36N2O6 |
![Oseltamivir Impurity 91](/) |
Oseltamivir Impurity 91 |
|
|
![Oseltamivir Impurity 80](/) |
Oseltamivir Impurity 80 |
|
|
![Oseltamivir Impurity 72](/) |
Oseltamivir Impurity 72 |
|
|
![4(1H)-Quinazolinone, 6,8-dibromo-3-cyclohexyl-2,3-dihydro-](/CAS/20210305/GIF/2512203-87-9.gif) |
4(1H)-Quinazolinone, 6,8-dibromo-3-cyclohexyl-2,3-dihydro- |
2512203-87-9 |
C14H16Br2N2O |
![Linagliptin impurity KH-3](/CAS/20210305/GIF/2279114-27-9.gif) |
Linagliptin impurity KH-3 |
2279114-27-9 |
C30H37N7O6 |
![11β-ヒドロキシ-21-アセトキシプレグナ-1,4,16-トリエン-3,20-ジオン](/CAS/GIF/3044-42-6.gif) |
11β-ヒドロキシ-21-アセトキシプレグナ-1,4,16-トリエン-3,20-ジオン |
3044-42-6 |
C23H28O5 |
![1-[(1,1-ジメチルエチル)アミノ]-3-[[4-(4-モルホリニル)-1,2,5-チアジアゾール-3-イル]オキシ]-2-プロパノール?マレイン酸](/CAS/GIF/57073-55-9.gif) |
1-[(1,1-ジメチルエチル)アミノ]-3-[[4-(4-モルホリニル)-1,2,5-チアジアゾール-3-イル]オキシ]-2-プロパノール?マレイン酸 |
57073-55-9 |
C17H28N4O7S |
![Ampicillin Impurity U](/) |
Ampicillin Impurity U |
|
|
![Canagliflozin Hydroperoxide Impurity](/) |
Canagliflozin Hydroperoxide Impurity |
|
|
![(E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid](/CAS/20210305/GIF/40038-46-8.gif) |
(E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid |
40038-46-8 |
C13H10N2O3 |
![Sitagliptin EP Impurity 6](/) |
Sitagliptin EP Impurity 6 |
|
|
![Vonoprazan-005](/CAS/20210305/GIF/2514735-09-0.gif) |
Vonoprazan-005 |
2514735-09-0 |
C33H27F3N4 |
![D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester](/CAS/20210305/GIF/1469771-46-7.gif) |
D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester |
1469771-46-7 |
C17H23NO4S2 |
![(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide](/) |
(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide |
|
|
![1-Demethyl Hydroxy Daunomycinone](/CAS/20210305/GIF/58199-98-7.gif) |
1-Demethyl Hydroxy Daunomycinone |
58199-98-7 |
C20H16O9 |
![(S)-2-(butylsulfonamido)-3-(4-(4-(1-methylpiperidin-4-yl)butoxy)phenyl)propanoic acid](/CAS/20210305/GIF/1631053-75-2.gif) |
(S)-2-(butylsulfonamido)-3-(4-(4-(1-methylpiperidin-4-yl)butoxy)phenyl)propanoic acid |
1631053-75-2 |
C23H38N2O5S |
![Loxoprofen Sodium Impurity 35](/) |
Loxoprofen Sodium Impurity 35 |
|
|
![Dashatinib impurity 46](/) |
Dashatinib impurity 46 |
|
|
![(R,S)Nアセチル3,4ジメトキシフェニルアラニン](/CAS/GIF/27313-65-1.gif) |
(R,S)Nアセチル3,4ジメトキシフェニルアラニン |
27313-65-1 |
C13H17NO5 |
![Oxytocin oxide impurity reference substance](/) |
Oxytocin oxide impurity reference substance |
|
|
![Troxipide Impurity 7](/) |
Troxipide Impurity 7 |
|
|
![Bendamustine Impurity 37A](/) |
Bendamustine Impurity 37A |
|
|
![Palbociclib Impurity 37](/) |
Palbociclib Impurity 37 |
|
|
![Pazufloxacin Impurity 16](/CAS/20210305/GIF/165071-10-3.gif) |
Pazufloxacin Impurity 16 |
165071-10-3 |
C14H10FNO6 |
![Pimecrolimus Impurity 4](/) |
Pimecrolimus Impurity 4 |
|
|
![Posaconazole Impurity 73](/) |
Posaconazole Impurity 73 |
|
|
![Rosuvastatin Impurity 90](/CAS/20210111/GIF/2226413-62-1.gif) |
Rosuvastatin Impurity 90 |
2226413-62-1 |
C38H44F2N6O8S2 |
![Tofacitinib Impurity 110](/) |
Tofacitinib Impurity 110 |
|
|
![Tofacitinib Impurity 115](/) |
Tofacitinib Impurity 115 |
|
|
![Trelagliptin Impurity 27](/) |
Trelagliptin Impurity 27 |
|
|
![Vildagliptin Impurity 30](/CAS/20200611/GIF/918830-94-1.gif) |
Vildagliptin Impurity 30 |
918830-94-1 |
C10H17NO2 |
![N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine](/CAS/20200401/GIF/CB84908513.gif) |
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine |
|
C13H19N5 |
![Tolvaptan Impurity 6](/CAS/20200611/GIF/1432725-24-0.gif) |
Tolvaptan Impurity 6 |
1432725-24-0 |
C18H19ClN2O2 |
![Esmolol impurity B](/) |
Esmolol impurity B |
|
|
![Esmolol impurity F](/) |
Esmolol impurity F |
|
|
![Diquafosol Impurity E](/) |
Diquafosol Impurity E |
|
|
![Bortezomib Impurity 39](/) |
Bortezomib Impurity 39 |
|
|
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2463617-49-2.gif) |
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](/CAS/20210111/GIF/906673-43-6.gif) |
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](/CAS/20210111/GIF/1651211-78-7.gif) |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
![(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/) |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
![(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide](/) |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|